Upgrade to SI Premium - Free Trial

Ligand Pharma (LGND)

285.60 -4.14 (1.43%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Ligand to Participate in September Investor Conferences August 26, 2026 7:00 AM - Globe NewsWire Form 4 LIGAND PHARMACEUTICALS For: Aug 12 Filed by: Espinoza Octavio August 14, 2026 5:06 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Aug 12 Filed by: Haas Jason August 14, 2026 5:05 PM - SEC Filing Leerink Starts Ligand Pharma (LGND) at Outperform August 14, 2026 9:29 AM - StreetInsider Ligand Pharma (LGND) Reiterated at Buy by Stifel After Chat With CEO, CFO August 14, 2026 8:21 AM - StreetInsider Form SCHEDULE 13G LIGAND PHARMACEUTICALS Filed by: Invesco Ltd. August 13, 2026 2:59 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Espinoza Octavio August 12, 2026 4:33 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Haas Jason August 12, 2026 4:24 PM - SEC Filing Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30 August 7, 2026 4:07 PM - SEC Filing Ligand Pharma (LGND) PT Raised to $345 at RBC Capital August 7, 2026 7:21 AM - StreetInsider Ligand Pharma (LGND) Tops Q2 EPS by 42c August 6, 2026 7:17 AM - StreetInsider Form 8-K LIGAND PHARMACEUTICALS For: Aug 06 August 6, 2026 7:05 AM - SEC Filing Ligand Reports Second Quarter 2026 Financial Results August 6, 2026 7:01 AM - Globe NewsWire Form 4 LIGAND PHARMACEUTICALS For: Aug 03 Filed by: Reardon Andrew August 4, 2026 6:43 PM - SEC Filing Ligand Pharma (LGND) PT Raised to $326 at Oppenheimer August 3, 2026 5:51 AM - StreetInsider Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026 July 23, 2026 7:00 AM - Globe NewsWire Form S-8 LIGAND PHARMACEUTICALS July 22, 2026 4:53 PM - SEC Filing Citi resumes Ligand Pharma coverage with Buy rating, $387 target July 21, 2026 5:01 AM - StreetInsider Ligand Pharma (LGND) PT Raised to $335 at Benchmark as XOMA Royalty Cash Acquisition Completed July 16, 2026 7:57 AM - StreetInsider Ligand Pharma (LGND) PT Raised to $340 at RBC Capital July 15, 2026 6:25 AM - StreetInsider Form 8-K LIGAND PHARMACEUTICALS For: Jul 14 July 14, 2026 9:20 AM - SEC Filing Ligand completes acquisition of XOMA Royalty at $39 per share July 14, 2026 9:01 AM - StreetInsider Ligand completes $739M acquisition of XOMA Royalty July 14, 2026 9:00 AM - StreetInsider Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets July 14, 2026 9:00 AM - StreetInsider XOMA Royalty Announces Closing of Its Acquisition by Ligand July 14, 2026 9:00 AM - StreetInsider Ligand Pharma (LGND) PT Raised to $388 at BofA Securities July 9, 2026 5:13 AM - StreetInsider Ligand Pharma (LGND) PT Raised to $332 at Stifel as Xoma Asset Acquisition Announced July 8, 2026 7:22 AM - StreetInsider Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Reardon Andrew July 6, 2026 5:11 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Espinoza Octavio July 6, 2026 5:11 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Davis Todd C July 6, 2026 5:10 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Reardon Andrew July 1, 2026 4:57 PM - SEC Filing Form 8-K LIGAND PHARMACEUTICALS For: Jun 25 June 25, 2026 5:01 PM - SEC Filing Ligand closes $700M convertible notes offering due 2031 June 25, 2026 4:01 PM - StreetInsider Ligand Announces Closing of Convertible Senior Notes Offering June 25, 2026 4:01 PM - Globe NewsWire Ligand prices $625M convertible notes due 2031 at 0% interest June 23, 2026 4:00 AM - StreetInsider Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering June 23, 2026 4:00 AM - Globe NewsWire Form 8-K LIGAND PHARMACEUTICALS For: Jun 22 June 22, 2026 7:12 AM - SEC Filing Ligand plans $550M convertible notes offering due 2031 June 22, 2026 7:01 AM - StreetInsider Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031 June 22, 2026 7:00 AM - Globe NewsWire Form 4 LIGAND PHARMACEUTICALS For: Jun 16 Filed by: Sabba Stephen L June 18, 2026 8:38 AM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Sabba Stephen L June 16, 2026 4:31 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 12 Filed by: Haas Jason June 15, 2026 9:07 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 05 Filed by: Aryeh Jason June 12, 2026 5:27 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 10 Filed by: LAMATTINA JOHN L June 12, 2026 5:26 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Haas Jason June 12, 2026 4:11 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Aryeh Jason June 11, 2026 12:22 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Aryeh Jason June 10, 2026 4:45 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: LAMATTINA JOHN L June 10, 2026 4:08 PM - SEC Filing Form 144 LIGAND PHARMACEUTICALS Filed by: Aryeh Jason June 10, 2026 1:41 PM - SEC Filing Ligand Announces 2026 Investor Day in New York City June 10, 2026 7:00 AM - Globe NewsWire Form 4 LIGAND PHARMACEUTICALS For: Jun 05 Filed by: Zimmermann Martine June 9, 2026 7:42 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 05 Filed by: Sabba Stephen L June 9, 2026 7:42 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 05 Filed by: LAMATTINA JOHN L June 9, 2026 7:41 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 05 Filed by: KOZARICH JOHN W June 9, 2026 7:40 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 05 Filed by: Haas Jason June 9, 2026 7:36 PM - SEC Filing Form 4 LIGAND PHARMACEUTICALS For: Jun 05 Filed by: Gray Nancy Ryan June 9, 2026 7:35 PM - SEC Filing Form 8-K LIGAND PHARMACEUTICALS For: Jun 05 June 9, 2026 4:03 PM - SEC Filing Full Article List